Joost Wiersinga

Joost, Professor of Medicine, chairs the Division of Infectious Diseases, Department of Medicine, Amsterdam UMC, the Netherlands. He received his medical training at the University of Amsterdam with additional courses at the Mayo Clinic (Rochester, Minnesota) and the National Institutes of Health (NIH, Bethesda, MD). More recently he completed his MBA in Healthcare from the triple-crown accredited Amsterdam Business School.

Dr. Wiersinga chaired the infection group of the Surviving Sepsis Campaign international guidelines for the management of sepsis and septic shock 2021 in addition to the Dutch national SWAB antibiotic treatment guidelines on both sepsis and pneumonia. He currently chairs the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES).

The focus of his research group is on host-pathogen interactions and innate immune responses in sepsis Recent interests include the role of the microbiome during sepsis and antiviral treatment for COVID-19. His work has been published in among others JAMA, BMJ, Lancet Infect Dis, and New England Journal of Medicine.